John A Wagner

Title: John A. Wagner: Innovator in Anti-Diabetic Treatments

Introduction

John A. Wagner is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of type II diabetes. His innovative approach focuses on the use of fused aromatic compounds that exhibit anti-diabetic activity.

Latest Patents

Wagner holds a patent for a method of treatment using fused aromatic compounds having anti-diabetic activity. This patent describes fused aromatic compounds of Formula I as PPAR gamma agonists or partial agonists. These compounds are useful for weekly dosing in the treatment or control of type II diabetes, including conditions such as hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes. He has 1 patent to his name.

Career Highlights

John A. Wagner is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative treatments that can improve the quality of life for individuals suffering from diabetes.

Collaborations

Wagner has collaborated with notable colleagues in his field, including Peter T. Meinke and Andrew Evan Denker. These collaborations have contributed to the advancement of research and development in anti-diabetic therapies.

Conclusion

John A. Wagner's contributions to the field of diabetes treatment through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the lives of many individuals affected by type II diabetes.